Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals

Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals

Bibliographic Details
Main Authors:	Cull, C, Holman, R, Turner, R
Format:	Journal article
Published:	1997

Similar Items

Glycaemic improvement over one year in a double-blind trial of acarbose in 1,946 NIDDM patients
by: Holman, R, et al.
Published: (1996)

Effects of ethnicity on metabolic control during the first six years of NIDDM
by: Davis, T, et al.
Published: (1997)

Insulin use in NIDDM. Rationale based on pathophysiology of disease.
by: Turner, R, et al.
Published: (1990)

No glycemic benefit from guar administration in NIDDM.
by: Holman, R, et al.
Published: (1987)

Risk factors predicting progression of diabetic retinopathy over six years in 1579 NIDDM patients
by: Stratton, I, et al.
Published: (1996)

Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemia.
by: Holman, R, et al.
Published: (1991)

Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
by: Turner, R, et al.
Published: (1997)

CIGMA as a tool in the study of NIDDM.
by: Turner, R, et al.
Published: (1988)

Segregation analysis of NIDDM in Caucasian families.
by: Cook, J, et al.
Published: (1994)

Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
by: Rachman, J, et al.
Published: (1996)

Pathogenesis of NIDDM--a disease of deficient insulin secretion.
by: Turner, R, et al.
Published: (1988)

U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM.
by: Davis, T, et al.
Published: (1997)

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
by: Rachman, J, et al.
Published: (1998)

UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
by: Keavney, B, et al.
Published: (1995)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
by: Turner, R, et al.
Published: (1999)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
by: Turner, R, et al.
Published: (1999)

Basal normoglycemia attained with chlorpropamide in mild diabetes.
by: Holman, R, et al.
Published: (1978)

Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
by: Rachman, J, et al.
Published: (1997)

Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices
by: Antonella Corcillo, et al.
Published: (2017-07-01)

HIV vaccines: an attainable goal?
by: Lucy Reynell, et al.
Published: (2012-02-01)

Cumprindo metas Attaining goals
by: Bernardo Gontijo, et al.
Published: (2005-06-01)

Thyroid dysfunction and its relation with diabetes mellitus (NIDDM)
by: H.R.Bazrafshan (M.D), et al.
Published: (2000-03-01)

Familial association and lambda s for diabetes, obesity, high triglycerides and low HDL-cholesterol in sibs of NIDDM patients.
by: Levy, J, et al.
Published: (1997)

Familial association and lambda s for diabetes, obesity, high triglycerides and low HDL-cholesterol in sibs of NIDDM patients
by: Levy, J, et al.
Published: (1997)

RESTING THE BETA-CELLS WITH INSULIN IN NIDDM DOES NOT IMPROVE BETA-CELL FUNCTION NOR PROINSULIN PROCESSING
by: Rachman, J, et al.
Published: (1995)

U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM.
by: Dudley, C, et al.
Published: (1995)

A STUDY OF MOXONIDINE’S METABOLIC EFFECTS IN PATIENTS WITH ARTERIAL HYPERTENSION AND NIDDM
by: D. V. Nebieridze, et al.
Published: (2001-04-01)

Will the current coronavirus disease 2019 affect progress in the attainment of sustainable development goals in Africa?
by: Brian Chanda Chiluba, et al.
Published: (2020-01-01)

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.
by: Rachman, J, et al.
Published: (1997)

Successful antibiotic stewardship: a realistic and attainable goal
by: D. Subrayen, et al.
Published: (2014-04-01)

The attainment of organization goals through appropriate selection of sub-unit goals.
by: Charnes, A.
Published: (2009)

Reduced specificity of personal goals and explanations for goal attainment in major depression.
by: Joanne M Dickson, et al.
Published: (2013-01-01)

Goal Attainment Scaling in rehabilitation: An educational review providing a comprehensive didactical tool box for implementing Goal Attainment Scaling
by: Rachel Bard-Pondarré, et al.
Published: (2023-06-01)

Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients
by: R. Coifman, et al.
Published: (1999-01-01)

Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States
by: Alexa C. Klimchak, et al.
Published: (2020-03-01)

Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
by: Rachman, J, et al.
Published: (1996)

No evidence for mutations in a putative beta-cell ATP-sensitive K+ channel subunit in MODY, NIDDM, or GDM.
by: Zhang, Y, et al.
Published: (1995)

No evidence for excess allele-sharing on chromosome 2q (region of NIDDM1) in a large sibship collection
by: Cassell, P, et al.
Published: (1997)

Attaining the 2030 Sustainable Development Goal of Quality Education /
by: Birdthistle, Naomi, editor 646771, et al.
Published: (2020)

Goal Attainment and Quality of Life through Inclusive College
by: Kate Strater, et al.
Published: (2024-02-01)